Credit: Robert Boston, Washington University
Personalized melanoma vaccines developed at Washington University in St. Louis have been shown in a small clinical trial to marshal a powerful immune response against unique mutations in patients' tumors. Pictured is Gerald Linette, MD, PhD and Beatriz Carreno, PhD, who led the team that developed the vaccines.